{
  "abstract": "While it is recognised that antidepressants have a role in the management of depression when used appropriately, there has been increasing concern about the potential for adverse effects associated with their longer-term use. 1–3 NHS England has recognised the importance of reducing inappropriate antidepressant prescribing and addressing the withdrawal problems that can be associated with discontinuation of antidepressants.1 3 4",
  "authors": [
    {
      "affiliations": [
        "University College London, London, UK"
      ],
      "name": "Mark Horowitz"
    },
    {
      "affiliations": [
        "Pharmacy, Royal Cornwall Hospitals NHS Trust, Truro, UK"
      ],
      "name": "Michael Wilcock"
    }
  ],
  "title": "Hyperbolic tapering of antidepressants: where are we now?",
  "uid": "23ab60d5-3ec3-576e-ba62-6795dfb8b6b4"
}